Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...

Fact checked by Jennifer Klump Key Takeaways The FDA approved the obesity drug Wegovy as a treatment for people with MASH ...

Rosa Tellez-Moore finds hope and healing through groundbreaking research at UC San Diego Health Rosa Tellez-Moore is grateful ...

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Thousands more people in England have been referred for liver cancer checks thanks to the expansion of an NHS scheme that ...

Liver checks are being offered at supermarkets and football matches and in offices as part of efforts to catch cancer early.

Thousands of people across England have been referred for liver cancer checks following the expansion of mobile scanning ...

Thousands more people in England have been referred for liver cancer checks thanks to the expansion of an NHS scheme that sends scanning trucks into the community. The on-the-spot scans offered by the ...

Rates of chronic liver disease during pregnancy are rising partly due to MASLD and the downward trend of chronic viral hepatitis.

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

In patients with hepatocellular carcinoma (HCC), hyponatremia is an independent predictor of increased rates of in-hospital mortality, with a greater impact reported among those with cirrhosis, ...